Kevin A. Scott's Avatar

Kevin A. Scott

@sculpturatus

Director of Discovery Chemistry at Stealth Medicines Evolution-Guided Pharmacology, Drug Discovery, Chemical Immunology, Aging

1,835
Followers
974
Following
185
Posts
07.10.2023
Joined
Posts Following

Latest posts by Kevin A. Scott @sculpturatus

thank you!

07.03.2026 23:37 πŸ‘ 1 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Preview
A proteome-wide dependency map of protein interaction motifs Nature Structural & Molecular Biology, Published online: 06 March 2026; doi:10.1038/s41594-026-01762-2AmbjΓΈrn and Meeusen et al. functionally characterize all reported and a comprehensive set of predicted short linear motifs (SLiMs) using base-editing screens, identifying 450 reported and 264 predicted SLiMs required for normal cell proliferation.

ICYMI: New online: A proteome-wide dependency map of protein interaction motifs

07.03.2026 20:51 πŸ‘ 10 πŸ” 5 πŸ’¬ 0 πŸ“Œ 0

woooooo we got the cover! fun article to write, check it out.

07.03.2026 23:01 πŸ‘ 5 πŸ” 0 πŸ’¬ 1 πŸ“Œ 0
Post image

πŸ“’Our latest issue is now online!

Check out the review behind the cover by @sculpturatus.bsky.social & co. at @uarizona.bsky.social looking at the history, synthesis and medicinal use of cantharidin, LB-100, and their analogs #medchem

pubs.rsc.org/en/content/a...

25.02.2026 14:43 πŸ‘ 0 πŸ” 1 πŸ’¬ 0 πŸ“Œ 1

That's a good point. Vincent do you have a good paper that describes these statistical powers?

21.02.2026 23:48 πŸ‘ 0 πŸ” 0 πŸ’¬ 1 πŸ“Œ 0

This often plays out in phase one though. Phase III will be the real test.

21.02.2026 22:07 πŸ‘ 0 πŸ” 0 πŸ’¬ 1 πŸ“Œ 0

Do you mean toxicity?

21.02.2026 21:11 πŸ‘ 0 πŸ” 0 πŸ’¬ 1 πŸ“Œ 0
Post image

β€œAI” means a hundred different things. In drug discovery, it already works for ADME, PK/PD, and molecule optimization β€” and that’s real progress. But most failures come from target biology, not chemistry. To bend clinical success, AI must move from optimization to causality.

21.02.2026 20:12 πŸ‘ 2 πŸ” 0 πŸ’¬ 1 πŸ“Œ 0
Post image Post image

cattle dog (brattle)

21.02.2026 16:08 πŸ‘ 3 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Post image

happy friday

20.02.2026 16:54 πŸ‘ 4 πŸ” 0 πŸ’¬ 1 πŸ“Œ 0

yea it's true. but fun to noodle around a bit. and useful when i have something specific in mind.

20.02.2026 05:23 πŸ‘ 0 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0

it definitely can eat up time but i made this one in five minutes. took me
30 minutes to learn.

20.02.2026 04:59 πŸ‘ 0 πŸ” 0 πŸ’¬ 1 πŸ“Œ 0

i like seeing them in my feed even if i don't engage. i would also just love to see the answers posted. maybe lazy on my part but i like to see that stuff.

20.02.2026 04:58 πŸ‘ 13 πŸ” 0 πŸ’¬ 1 πŸ“Œ 0

i don't understand the question

20.02.2026 01:52 πŸ‘ 0 πŸ” 0 πŸ’¬ 1 πŸ“Œ 0
Post image

You can create images like this in a couple minutes using 100% free software. Check out tutorials by @bradyajohnston.bsky.social

19.02.2026 23:59 πŸ‘ 6 πŸ” 2 πŸ’¬ 0 πŸ“Œ 1
Post image

PyMol + Blender is cool. Learned this from @bradyajohnston.bsky.social

19.02.2026 23:46 πŸ‘ 6 πŸ” 1 πŸ’¬ 0 πŸ“Œ 0

wow this is super cool. congrats team

18.02.2026 23:31 πŸ‘ 1 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0

disodium glutamate

18.02.2026 00:32 πŸ‘ 1 πŸ” 0 πŸ’¬ 1 πŸ“Œ 0
Post image

FDA Approval Watch: Neurodegeneration is getting hot. Small-molecule programs targeting sigma receptors, LRRK2, brain cortisol, ISR stress pathways, and RNA splicing are advancing across Alzheimer’s, Parkinson’s, ALS, and rare ataxias β€” pushing beyond symptomatic care toward disease modification.

17.02.2026 20:13 πŸ‘ 3 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Post image

FDA approved ADQUEY (difamilast) for atopic dermatitis. A topical PDE4 inhibitor that reduces inflammatory signaling, offering a non-steroidal option for patients β‰₯2 years old. Targeted, mechanism-based small-molecule therapies keep advancing.

17.02.2026 14:39 πŸ‘ 3 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0

excellent photo

17.02.2026 02:17 πŸ‘ 0 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0

this is impressive actually

15.02.2026 03:58 πŸ‘ 1 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0

430 picometer what??

12.02.2026 02:22 πŸ‘ 3 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Post image

FDA Approval of the Month – January
Copper histidinate is now the first FDA-approved treatment for Menkes disease. A major milestone for a devastating X-linked disorder, showing how early, biology-driven intervention can meaningfully improve outcomes for patients and families.

27.01.2026 15:36 πŸ‘ 2 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0

tell me more about MN getting rid of ice cream

25.01.2026 04:36 πŸ‘ 0 πŸ” 0 πŸ’¬ 1 πŸ“Œ 0
Post image

excuse me do you have a moment to talk about ball

01.01.2026 18:27 πŸ‘ 4 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Preview
The Role of Natural Product Chemistry in Drug Discovery: Two Decades of Progress and Perspectives Natural products (NPs) have long played a pivotal role in medicine, serving as both lead compounds and approved drugs in diverse therapeutic areas. Inspired by the 2004 review β€œThe Role of Natural Pro...

as more and more synthetic drugs resemble natural products in their properties, this is a timely overview of natural products in the last 20 years of medicine.

pubs.acs.org/doi/10.1021/...

01.01.2026 16:34 πŸ‘ 8 πŸ” 1 πŸ’¬ 0 πŸ“Œ 0
Preview
Investigating the bioorthogonality of isocyanides Isocyanides have been applied in bioorthogonal reactions as triggers for uncaging reactions. However, emerging evidence suggests that they may label proteins covalently. We synthesised a fluorophore-conjugated isocyanide and analysed its protein reactivity. Our results suggest that isocyanides cannot be considered

Let's start the year off right with an exciting paper post!

In this @chemcomm.rsc.org paper, the groups of @meganwright.bsky.social and Stuart Warriner investigate the metal-independent labeling of proteins using isocyanides.
pubs.rsc.org/en/content/artic...
#ChemBio #ChemSky #CovalentInhibitors

01.01.2026 14:01 πŸ‘ 12 πŸ” 3 πŸ’¬ 0 πŸ“Œ 0

cool right?

01.01.2026 03:00 πŸ‘ 0 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0

πŸ˜‚

31.12.2025 18:13 πŸ‘ 1 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0